"We're excited about participating in Rhode Island's rejuvenation in the biotechnology space," said Lifespan's medical ...

Launched as a public–private partnership funded by the Foundation for the National Institutes of Health, the Study to Advance ...

One of the exciting things about modern medicine is that it is making increasingly rapid advancements in a number of key ...

The prevalence of low amyloid levels in Black people opens up a host of questions regarding the development of Alzheimer’s ...

If you are struggling to afford the cost to remove painful bunions from your feet, a clinical trial in Dayton may be your ...

Initial ACR-368 Phase 2b clinical data in patients with ovarian or endometrial cancers (n=26; 10 OncoSignature-positive and 16 ...

The Kalazar treatment drug has reached an exciting milestone as it enters the crucial phase two clinical trials in Ethiopia.

By definition, rare diseases affect only a small number of patients. However, recruiting cohorts of sufficient size is not ...

A clinical psychologist at Yale University resumed her testimony Wednesday in the civil trial involving the state's Youth ...

Researchers at Texas Children's Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas ...

IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic cancer vaccines based on its T-win ® platform, today announced the acceptance of ...